Adial Pharmaceuticals Inc
NASDAQ:ADIL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Adial Pharmaceuticals Inc
NASDAQ:ADIL
|
US |
|
China Renaissance Holdings Ltd
OTC:CSCHF
|
CN |
|
C
|
Cooper-Standard Holdings Inc
F:C31
|
US |
|
I
|
Iss A/S
XMUN:QJQ
|
DK |
|
E
|
Estrima SpA
MIL:BIRO
|
IT |
|
W
|
Wiit SpA
F:9PC
|
IT |
|
Comer Industries SpA
MIL:COM
|
IT |
|
W
|
Wacker Chemie AG
DUS:WCH
|
DE |
|
T
|
Texas Instruments Inc
F:TII
|
US |
|
Aegon NV
AEX:AGN
|
NL |
|
Q
|
QinetiQ Group PLC
F:QY6
|
UK |
|
F
|
Finning International Inc
OTC:FINGF
|
CA |
|
V
|
Verrica Pharmaceuticals Inc
F:1NE
|
US |
|
M
|
MSCI Inc
SWB:3HM
|
US |
|
F
|
Fifth Third Bancorp
LSE:0IM1
|
US |
|
ONE Gas Inc
NYSE:OGS
|
US |
Wall St Price Targets
ADIL Price Targets Summary
Adial Pharmaceuticals Inc
According to Wall Street analysts, the average 1-year price target for
ADIL is 7.14 USD with a low forecast of 6.06 USD and a high forecast of 8.4 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is ADIL's stock price target?
Price Target
7.14
USD
According to Wall Street analysts, the average 1-year price target for
ADIL is 7.14 USD with a low forecast of 6.06 USD and a high forecast of 8.4 USD.